Prosecution Insights
Last updated: April 19, 2026
Application No. 17/177,770

LIQUID CHROMATOGRAPHY TECHNIQUE

Final Rejection §103
Filed
Feb 17, 2021
Examiner
SCHMITT, BENJAMIN R
Art Unit
2852
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Silcotek Corp.
OA Round
8 (Final)
85%
Grant Probability
Favorable
9-10
OA Rounds
2y 7m
To Grant
99%
With Interview

Examiner Intelligence

Grants 85% — above average
85%
Career Allow Rate
1030 granted / 1218 resolved
+16.6% vs TC avg
Strong +16% interview lift
Without
With
+15.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
40 currently pending
Career history
1258
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
45.7%
+5.7% vs TC avg
§102
29.8%
-10.2% vs TC avg
§112
16.5%
-23.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1218 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1, 3-4, 6, and 9 are rejected under 35 U.S.C. 103 as being unpatentable over Carr et al. (U.S. Pub. 2015/0024152) in view of Zhao et al (CN 105699507), further in view of Smith et al. (“The Deposition and Functionalization of Silicon-Based Materials to Prevent Surface Corrosion, Adsorption, Contamination and Catalytic Interactions” Oct. 2009 – cited on Applicant’s 07/29/2025 IDS), and further in view of SilcoTek ("How To Stop HPLC Corrosion, Protein Fouling, And Contamination" – Feb 24, 2017; available at: https://www.silcotek.com/blog/how-to-stop-hplc-corrosion-protein-fouling-and-contamination). Regarding claim 1, Carr discloses (Fig. 1) a liquid chromatography technique (see par. [0002]), comprising: providing a liquid chromatography system (see pars. [0002] and [0024]) having a coated stainless steel fluid- contacting element 100 (i.e. the column: [0036]); and transporting a fluid (which can have biological components: see Abstract, par. [0007]) in contact with [0034] the coated stainless steel fluid-contacting element 100 (see pars. [0002], [0026], [0036]); wherein the coated stainless steel fluid-contacting element 100 has a coating 140 [0035]-[0036], the coating including carbon, silicon, oxygen, and hydrogen (see par. [0035]; note: “mixtures thereof” which, for example, could be a mixture of SiCxHy and one of the oxides), and a decomposition (see pars. [0019] and [0026]), and an oxidation (i.e. the coating can include an oxide: [0021]/[0035]); and the liquid chromatography system having a frit [0034]. Carr does not disclose the fluid includes adenosine triphosphate. Zhao discloses the fluid includes adenosine triphosphate (Abstract: ATP detecting; in HPLC with column: see Preferred Embodiment section). Since the art recognizes that Carr’s chromatography system is suitable for analyzing bioanalytical separations (see Carr: Abstract, and par. [0007]), and Zhao’s fluid includes biological material (i.e. ATP: see Abstract), it would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify Carr’s LC technique so that the fluid includes adenosine triphosphate, as taught by Zhao-1. See MPEP 2144.07. Carr also does not disclose the coating includes a functionalization. Smith discloses the coating includes a functionalization (see pages/slides 9-13). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to further modify Carr’s LC technique so that the coating includes a functionalization, as taught by Smith. Such a modification would be a use of a known technique (Smith’s coating) to improve similar devices (Carr’s) in the same way – see MPEP(I)(C); and would improve the inertness of the coating (see Smith, page/slide 13). Finally, Carr does not disclose that the coated stainless steel fluid-contacting permits anti-stiction transport of the fluid. SilcoTek (see the article cited above) discloses that a coated stainless steel fluid-contacting permits anti-stiction transport of the fluid (i.e. “proteins don’t stick to Dursan” – that is, the coating on the HPLC parts – see bottom p. 3, top of p.4). Thus, it would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to further modify Carr’s LC technique so that the coated stainless steel fluid-contacting permits anti-stiction transport of the fluid, as taught by SilcoTek. Such a modification would prevent protein carryover and fouling (see SilcoTek: bottom p. 3, top of p.4). Regarding claims 3-4, Carr is applied as above and discloses each of the fitting and the pump head have the coating [0023]. Regarding claim 6, Carr discloses (Fig. 1) the liquid chromatography system has a stationary phase (see pars. [0002] and [0034]), the stationary phase having particles having a size of less than 6 micrometers (necessarily so, when the coating thickness is less than 6μm: [0032]). Regarding claim 9, Carr discloses (Fig. 1) the liquid technique is high performance liquid chromatography (see pars. [0040] and [0044]). Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Carr et al. (U.S. Pub. 2015/0024152) in view of Zhao et al (CN 105699507), further in view of Smith et al. (“The Deposition and Functionalization of Silicon-Based Materials to Prevent Surface Corrosion, Adsorption, Contamination and Catalytic Interactions”), further in view of SilcoTek ("How To Stop HPLC Corrosion, Protein Fouling, And Contamination"), and further in view of Van Alstine et al. (WO 2004/082801). Regarding claim 7, Carr’s modified device is applied as above, and further discloses the liquid chromatography system has a stationary phase (see pars. [0002] and [0034]). Carr does not disclose the stationary phase having particles being hydrophobic. Van Alstine discloses the stationary phase having particles being hydrophobic (Van Alstine: Background, p. 2). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify Carr’s LC technique so that the stationary phase has particles that are hydrophobic, as taught by Van Alstine. Such a modification would stabilize and control the analyte interactions with the target and medium (Van Alstine: Background, p. 2). Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over Carr et al. (U.S. Pub. 2015/0024152) in view of Zhao et al (CN 105699507), further in view of Smith et al. (“The Deposition and Functionalization of Silicon-Based Materials to Prevent Surface Corrosion, Adsorption, Contamination and Catalytic Interactions”), further in view of SilcoTek ("How To Stop HPLC Corrosion, Protein Fouling, And Contamination"), further in view of Gjerde et al. (U.S. Patent 5,997,742), further in view of Kitagawa (U.S. Pub. 2007/0144977), and further in view of Casey et al. (WO 2011/161481). Regarding claim 8, Carr’s modified device is applied as above, and further discloses the liquid chromatography system includes a coated metallic column [0034]. Carr does not disclose the liquid chromatography system includes a solvent reservoir, a solvent degasser, a gradient valve, a mixing vessel, a high-pressure pump, switching valves, a sample injection loop, a pre-column portion, a detector, a data acquisition system, and a waste collector. Gjerde discloses (Figs. 1-7) the liquid chromatography system includes a solvent reservoir 12 (col. 16, lines 11-12), a solvent degasser (col. 12, lines 54-58), a sample injection loop 18/22 (col. 16, lines 16-18), a pre-column portion (anything before column 26, such as guard disc 24: see Fig. 7), a detector 28 (col. 16, line 21), and a data acquisition system (which records tha chromatograms shown in Figs. 1-5). Kitagawa discloses (Fig. 1) the liquid chromatography system includes a gradient valve [0024], a mixing vessel (mixer: [0017]), a high-pressure pump [0005], and switching valves [0066]. Casey discloses the liquid chromatography system includes a waste collector [0055]. It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify Carr’s LC technique so that the liquid chromatography system includes a solvent reservoir, a solvent degasser, a gradient valve, a mixing vessel, a high-pressure pump, switching valves, a sample injection loop, a pre-column portion, a detector, a data acquisition system, and a waste collector, as taught by Gjerde, Kitagawa, and Casey. Such a modification would be merely a combination of prior art elements according to known methods to yield predictable results: see MPEP 2143(I)(A). Claims 10-12 are rejected under 35 U.S.C. 103 as being unpatentable over Carr et al. (U.S. Pub. 2015/0024152) in view of Zhao et al (CN 105699507), further in view of Smith et al. (“The Deposition and Functionalization of Silicon-Based Materials to Prevent Surface Corrosion, Adsorption, Contamination and Catalytic Interactions”), further in view of SilcoTek ("How To Stop HPLC Corrosion, Protein Fouling, And Contamination"), further in view of Von Doehren et al. (EP 2597460). Regarding claims 10-12, Carr’s modified device is applied as above, but does not disclose the liquid technique is ultra high performance liquid chromatography; the liquid technique is partitioned high performance liquid chromatography; and the liquid technique is partitioned ultra high performance liquid chromatography. Von Doehren discloses the liquid technique is ultra high performance liquid chromatography [0009]; the liquid technique is partitioned high performance liquid chromatography (the HLPC/UHLPC technique can be done with a partition: [0002]); and the liquid technique is partitioned ultra high performance liquid chromatography (the HLPC/UHLPC technique can be done with a partition: [0002]/[0009]). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify Carr’s LC technique so that the liquid technique is ultra high performance liquid chromatography; the liquid technique is partitioned high performance liquid chromatography; and the liquid technique is partitioned ultra high performance liquid chromatography, as taught by Von Doehren. Such a modification would be merely the application of a known technique to a known device (method, or product) ready for improvement to yield predictable results: see MPEP 2143(I)(D). Claims 13 and 15-17 are rejected under 35 U.S.C. 103 as being unpatentable over Carr et al. (U.S. Pub. 2015/0024152) in view of Zhao et al (CN 105699507), further in view of Smith et al. (“The Deposition and Functionalization of Silicon-Based Materials to Prevent Surface Corrosion, Adsorption, Contamination and Catalytic Interactions”), further in view of SilcoTek ("How To Stop HPLC Corrosion, Protein Fouling, And Contamination"), and further in view of Stout et al. (U.S. Patent 4,902,413). Regarding claims 13 and 15-17, Carr’s modified device is applied as above, but does not disclose the liquid technique is normal-phase chromatography, reversed-phase chromatography, size exclusion chromatography, or ion-exchange chromatography. Stout discloses the liquid technique can be normal-phase chromatography, reversed-phase chromatography, size exclusion chromatography, or ion-exchange chromatography (see col. 1, lines 24-31; and col. 5, lines 26-31). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify Carr’s LC technique so that the liquid technique is normal-phase chromatography, reversed-phase chromatography, size exclusion chromatography, or ion-exchange chromatography, as taught by Stout. Such a modification would be merely the application of a known technique to a known device (method, or product) ready for improvement to yield predictable results: see MPEP 2143(I)(D). Claim 14 is rejected under 35 U.S.C. 103 as being unpatentable over Carr et al. (U.S. Pub. 2015/0024152) in view of Zhao et al (CN 105699507), further in view of Smith et al. (“The Deposition and Functionalization of Silicon-Based Materials to Prevent Surface Corrosion, Adsorption, Contamination and Catalytic Interactions”), further in view of SilcoTek ("How To Stop HPLC Corrosion, Protein Fouling, And Contamination"), further in view of Gjerde et al. (U.S. Pub. 2016/0223441). Regarding claim 14, Carr’s modified device is applied as above, but does not disclose the liquid technique is displacement chromatography. Gjerde discloses the liquid technique can be displacement chromatography (see pars. [0121] and [0123]). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify Carr’s LC technique so that the liquid technique is displacement chromatography, as taught by Gjerde. Such a modification would be merely the application of a known technique to a known device (method, or product) ready for improvement to yield predictable results: see MPEP 2143(I)(D). Claims 5 and 18 are rejected under 35 U.S.C. 103 as being unpatentable over Carr et al. (U.S. Pub. 2015/0024152) in view of Zhao et al (CN 105699507), further in view of Bouvier et al (WO 2010/009311), further in view of Smith et al. (“The Deposition and Functionalization of Silicon-Based Materials to Prevent Surface Corrosion, Adsorption, Contamination and Catalytic Interactions” Oct. 2009 – cited on Applicant’s 07/29/2025 IDS), and further in view of SilcoTek ("How To Stop HPLC Corrosion, Protein Fouling, And Contamination" – Feb 24, 2017; available at: https://www.silcotek.com/blog/how-to-stop-hplc-corrosion-protein-fouling-and-contamination). Regarding claims 5 and 18, Carr discloses (Fig. 1) a liquid chromatography technique (see par. [0002]), comprising: providing a liquid chromatography system (see pars. [0002] and [0024]) having a coated stainless steel fluid- contacting element 100 (i.e. the column: [0036]); and transporting a fluid (which can have biological components: see Abstract, par. [0007]) in contact with [0034] the coated stainless steel fluid-contacting element 100 (see pars. [0002], [0026], [0036]); wherein the coated stainless steel fluid-contacting element 100 has a coating 140 [0035]-[0036], the coating including carbon, silicon, oxygen, and hydrogen (see par. [0035]; note: “mixtures thereof” which, for example, could be a mixture of SiCxHy and one of the oxides), and a decomposition (see pars. [0019] and [0026]), and an oxidation (i.e. the coating can include an oxide: [0021]/[0035]); and the liquid chromatography system having a frit [0034], a fitting [0023], and a pump head [0023], and wherein each of the frit, the fitting, and the pump head have a coating (see pars. [0023] and [0034]). Carr does not disclose the fluid includes adenosine triphosphate. Zhao discloses the fluid includes adenosine triphosphate (Abstract: ATP detecting; in HPLC with column: see Preferred Embodiment section). Since the art recognizes that Carr’s chromatography system is suitable for analyzing bioanalytical separations (see Carr: Abstract, and par. [0007]), and Zhao’s fluid includes biological material (i.e. ATP: see Abstract), it would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to modify Carr’s LC technique so that the fluid includes adenosine triphosphate, as taught by Zhao-1. See MPEP 2144.07. Carr also does not disclose the coating includes a functionalization. Smith discloses the coating includes a functionalization (see pages/slides 9-13). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to further modify Carr’s LC technique so that the coating includes a functionalization, as taught by Smith. Such a modification would be a use of a known technique (Smith’s coating) to improve similar devices (Carr’s) in the same way – see MPEP(I)(C); and would improve the inertness of the coating (see Smith, page/slide 13). Carr also does not disclose the liquid chromatography system has a valve; and wherein the valve has a coating. Bouvier discloses the liquid chromatography system has a valve (Summary of the Invention: p. 2), and wherein the valve, has a coating (Summary of the Invention: p. 2). It would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to further modify Carr’s LC technique so that the liquid chromatography system has a valve, and wherein the valve has a coating, as taught by Bouvier. Such a modification would protect the various components of the LC system (see Background section, p. 2). Finally, Carr does not disclose that the coated stainless steel fluid-contacting permits anti-stiction transport of the fluid. SilcoTek (see the article cited above) discloses that a coated stainless steel fluid-contacting permits anti-stiction transport of the fluid (i.e. “proteins don’t stick to Dursan” – that is, the coating on the HPLC parts – see bottom p. 3, top of p.4). Thus, it would have been obvious to one of ordinary skill in the art, before the effective filing date of the claimed invention, to further modify Carr’s LC technique so that the coated stainless steel fluid-contacting permits anti-stiction transport of the fluid, as taught by SilcoTek. Such a modification would prevent protein carryover and fouling (see SilcoTek: bottom p. 3, top of p.4). Response to Arguments Applicant's arguments filed 05/27/2025 have been fully considered but they are not persuasive. Applicant argues that the “SilcoTek” reference should be disqualified as prior art under the 102(b)(2)(C) exception, however, this exception only applies to references that are based on a filing date of a patent or a patent application. In the case of the “SilcoTek” reference, this reference is not a patent or patent application and the rejection is based on the publication date/date available to the public (“SilcoTek” is a publication available on the internet at the listed date); see MPEP 2152 and 2152.02(e). Thus, the “SilcoTek” reference cannot be excepted under the 102(b)(2)(C) exception. The examiner also notes that the “Smith” reference (i.e. “The Deposition and Functionalization of Silicon-Based Materials to Prevent Surface Corrosion, Adsorption, Contamination and Catalytic Interactions” Oct. 2009 – cited on Applicant’s 07/29/2025 IDS) discloses an anti-stiction property of a silicon-based coating (see slide 2). In addition, another reference to “SiloTek” (i.e. “Inert Dursan Prevent Protein & Biomolecule Sticking & Carryover – cited on Applicant’s 07/29/2025 IDS) also teaches an anti-stiction property of a coating for LC equipment (see pp. 1-2). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Benjamin Schmitt, whose telephone number is (571) 270-7930. The examiner can normally be reached M-F | 8:30-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Walter Lindsay can be reached at (571) 272-1674. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BENJAMIN R SCHMITT/Primary Examiner, Art Unit 2852
Read full office action

Prosecution Timeline

Feb 17, 2021
Application Filed
Jul 12, 2023
Non-Final Rejection — §103
Nov 17, 2023
Response Filed
Dec 07, 2023
Final Rejection — §103
Mar 12, 2024
Request for Continued Examination
Mar 16, 2024
Response after Non-Final Action
Mar 29, 2024
Non-Final Rejection — §103
Jul 03, 2024
Response Filed
Jul 12, 2024
Final Rejection — §103
Aug 20, 2024
Response after Non-Final Action
Sep 17, 2024
Request for Continued Examination
Sep 19, 2024
Response after Non-Final Action
Oct 02, 2024
Non-Final Rejection — §103
Jan 28, 2025
Response Filed
Feb 21, 2025
Final Rejection — §103
Apr 04, 2025
Notice of Allowance
May 27, 2025
Response after Non-Final Action
Jun 04, 2025
Response after Non-Final Action
Jul 29, 2025
Request for Continued Examination
Jul 30, 2025
Response after Non-Final Action
Aug 15, 2025
Non-Final Rejection — §103
Dec 18, 2025
Response Filed
Jan 30, 2026
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12601618
CASING FOR LIVESTOCK SENSOR AND LIVESTOCK SENSOR
2y 5m to grant Granted Apr 14, 2026
Patent 12604506
NON-COVALENT MODIFICATION OF GRAPHENE-BASED CHEMICAL SENSORS
2y 5m to grant Granted Apr 14, 2026
Patent 12596085
METHOD AND APPARATUS FOR SIMULTANEOUSLY MEASURING AIR CONTAINED HYDROGEN AND WATER VAPOR CONCENTRATIONS VIA A SINGLE MEMS THERMAL CONDUCTIVITY SENSOR
2y 5m to grant Granted Apr 07, 2026
Patent 12596004
SYSTEM FOR DETERMINING POSITION OF SERVICE PIN WITHIN PINHOLE OF WORK MACHINES
2y 5m to grant Granted Apr 07, 2026
Patent 12588946
CATHETER DISTAL FORCE SENSOR
2y 5m to grant Granted Mar 31, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

9-10
Expected OA Rounds
85%
Grant Probability
99%
With Interview (+15.6%)
2y 7m
Median Time to Grant
High
PTA Risk
Based on 1218 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month